Arena Soars Ahead Of FDA Committee Meeting
Posted on May 08, 2012 at 14:23 PM EDT

Shares of Arena Pharmaceuticals Inc. (Nasdaq: ARNA) soared 53 cents to $3.25 ahead of its meeting with a Food and Drug Advisory Committee on Thursday, May 10 for its obesity treatment Lorcaserin.




Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here